Genient Technologies Showcases Precision Fungal Genomics at MYCOCON 2026

Genient Technologies participated in MYCOCON 2026, the 6th International Conference on Fungal Infections and Mycology Masterclass, organized by the Fungal Infections Study Forum (FISF) in collaboration with the International Society for Human and Animal Mycology (ISHAM).

Held at Radisson RED, Chandigarh Mohali, India, the conference brought together leading experts in clinical mycology, infectious diseases, pulmonology, hematology, microbiology, and critical care.

Centered on the theme, “Bridging Science and Practice in Clinical Mycology: Diagnostics, Resistance, and Management,” the meeting provided an important platform for scientific exchange, clinical updates, and collaboration across academia, diagnostics, and healthcare practice.

Precision Genomics Solutions for Clinical Mycology

At Booth No. 16, Genient Technologies highlighted its expanding capabilities in fungal genomics and molecular diagnostics, demonstrating advanced workflows designed to support accurate fungal identification and clinically meaningful diagnostic insights.

• 18S rRNA Sequencing: NGS-based fungal identification workflows.
• ITS Sequencing: Precise fungal species characterization and identification.
• Fungal Metagenomics: Comprehensive sequencing approaches for complex fungal investigations.
• qPCR Solutions: Targeted detection of Candida and Dermatophytes.
• Molecular Diagnostics: Advanced diagnostic strategies for fungal infections.

Day 1: Strong Scientific Interest in Precision Genomics-Driven Mycology

Day 1 at MYCOCON 2026 made one thing clear: clinical mycology is moving decisively toward precision genomics.

The Genient Technologies team witnessed strong scientific interest around fungal metagenomics, ITS sequencing, and 18S fungal sequencing, reflecting the growing need for deeper and more clinically relevant fungal diagnostics.

Discussions with clinicians, microbiologists, and researchers reinforced the shift beyond conventional methods toward molecular approaches that improve organism identification, diagnostic insight, and clinical confidence.

Day 2: Momentum Builds Around Fungal Genomics in Clinical Diagnostics

Day 2 further underscored the growing momentum behind fungal genomics in clinical diagnostics.

The quality of scientific exchange around fungal metagenomics, ITS sequencing, and 18S fungal sequencing highlighted the field’s movement toward more precise, scalable, and clinically meaningful mycology workflows.

These interactions reaffirmed the importance of integrating molecular depth into routine fungal diagnostics to support better clinical decision-making.

A key highlight of the conference was the opportunity to engage in insightful discussion with Prof. David Denning on the evolving role of fungal genomics in shaping the future of diagnostics.

Advancing the Future of Fungal Diagnostics

For Genient Technologies, MYCOCON 2026 represented more than conference participation. It was an opportunity to contribute to an important scientific dialogue around diagnostics, resistance, and management, while building meaningful collaborations that strengthen the ecosystem of medical mycology in India and beyond.

As fungal infections continue to present increasing diagnostic complexity, Genient Technologies remains committed to advancing solutions that combine precision, speed, and molecular depth to improve clinical relevance and translational value.

Beyond Conventional Mycology. Where Precision Genomics Meets Clinical Diagnostics.